Latest Biotechnology, Pharmaceutical and Healthcare News from Novartis

14:48 EDT 22nd July 2018 | BioPortfolio

Here are the most relevant search results for "Novartis" found in our extensive news archives from over 250 global news sources.

More Information about Novartis on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Novartis for you to read. Along with our medical data and news we also list Novartis Clinical Trials, which are updated daily. BioPortfolio also has a large database of Novartis Companies for you to search.

Showing News Articles 1–25 of 75 from Novartis

Friday 29th June 2018

Drug development gets big data analytics boost

Today, the power of data analytics is informing strategies and business practices across industries. Football clubs are chasing players with specific skills to strengthen a side’s qualities, and Formula 1 teams are analyzing every turn of the wheel to squeeze out milliseconds to win races. The promise of big data and advanced analytics, which has been fueled by a quantum leap in computing over t...

Friday 1st June 2018

Open resources at Novartis help drive innovation

“Back in Argentina, you never think of going for a real drug, but coming to Novartis completely changed what I thought was possible,” says Bernardo Bazet Lyonnet, a postdoctoral researcher who first came to Novartis in 2016 as a Next Generation Scientist (NGS). This program invites talented scientists from around the world for a bi-directional learning exchange at the Novartis campus in Basel,...

Thursday 17th May 2018

Immuno-oncology researchers seek to build smart drug combos

Immunotherapies for cancer have been life-changing for patients who respond to them. Yet, overall, only about 20% of patients respond to these drugs. To expand the reach of these medicines, approximately 1 100 clinical trials have been launched by companies and research institutions over the past few years to test them in a range of combinations. This is a huge number of clinical trials – each ...

Monday 14th May 2018

Women in Science: Mimi Huizinga

As part of our “Novartis Presents: Women in Science” series, we ...

Monday 30th April 2018

Machine learning poised to accelerate drug discovery

A technology called machine learning is behind that seemingly magical ability of social networking websites to identify people in posted photos. By analyzing subtle patterns in facial features, machine learning algorithms can recognize people you’ve never tagged and might not even know.Machine learning is also transforming how scientists at Novartis discover and develop new drugs. Similar to how...

T.J. Sharpe on why clinical trials matter

For this installment of my blog ...

Tuesday 10th April 2018

African experts call for renewed global drive to beat malaria

African health experts warn that major advances in tackling malaria have led to widespread complacency and they are calling for a renewed effort to combat the disease.Although global malaria deaths fell more than 60% between 2000 and 2015, experts participating in a recent survey said they fear progress could stall unless national governments provide more funding, and international organizations t...

Thursday 5th April 2018

Meet Martin Grobusch, malaria fighter

Over the last 15 years, huge progress has been made in the fight against malaria, with the number of people dying from the disease dropping by almost two-thirds.1 Yet signs of resistance to existing antimalarial drugs are a rising concern, and the search is on for a replacement. Martin Grobusch is one of the researchers helping to test an experimental new Novartis antimalarial called KAF156. Since...

Monday 2nd April 2018

Counting on combos for complex liver diseases

The liver disease called NASH (non-alcoholic steatohepatitis) is stealthy. Patients don’t have symptoms until the latest stages of the disease, when it almost immediately becomes life threatening. It sneaks by doctors, too, since the disease can only be confirmed with a liver biopsy, an invasive procedure reserved for the seriously ill.NASH is also hard to treat. It’s a bit like four diseases ...

Thursday 22nd March 2018

DNA-encoded molecules provide a new edge in cancer drug hunts

Frederic Berst guides a team that builds libraries. Not the kind that hold books, but the kind that contain millions of chemicals that could someday become drugs. His team’s work, performed at the chemistry bench, is making it possible for drug hunters at Novartis to reimagine the way they search for new medicines for cancer and other diseases.There’s a strong need for new ways to find cancer ...

Tuesday 20th March 2018

Malaria is still disrupting lives, despite progress

Sitting in the small courtyard of his mud house, Adama Kone, the village chief in Bougoula in southeastern Mali, and his council of elders are talking about the importance of the malaria research being done there. Asked if they’ve ever had malaria, Kone and his advisors break into uproarious laughter. They explain they get it every year, and then mime vomiting and having diarrhea. ...

Wednesday 14th March 2018

Building “boot camps” for immune cells near tumors

A new wave of therapies is unleashing the body’s immune system on cancer, significantly extending lives. These agents, however, don’t work for everyone, so scientists are exploring new approaches that might enable immunotherapies to more effectively combat tumors.One idea, born of a team of bioengineers, involves loading baby-aspirin-sized scaffolds with immunotherapy agents and inserting them...

Friday 2nd March 2018

Positive gains are needed to accelerate change for women with lung disease

Last year, a report by the World Economic Forum1 predicted that gender parity is still over 200 years away. More recently, the #MeToo movement has brought sexual harassment in the workplace to the top of the news agenda, and rightly so. No one expects true gender equality to happen overnight, but it’s critical that continued positive progress is made in all areas of society and culture – inclu...

Friday 16th February 2018

Taking on obesity

As a cardiologist at the Veterans Affairs (VA) Medical Center in Boston, Will Chutkow treats patients who have served in the US military. Because these patients are predominantly male, drink and smoke at an above-average rate, and have had stressful jobs, they are in the high-risk group for heart disease. Many are also among the 38% of US adults who suffer from obesity – a major risk factor for ...

Tuesday 13th February 2018

Women in Science: Fionnuala Doyle

In this installment of “ ...

Monday 5th February 2018

Potential weight loss treatment takes shape with help from patients

James Zervios grew up in a time when schoolyard bullying was met with a shrug. Teased for his weight and picked last for sports teams, Zervios sought solace at the end of the day in the comforts of home. In his Italian and Greek household, comfort was often in the form of food. His family celebrated every life event with an Italian feast and gathered each Sunday for a four-course family dinner, so...

Wednesday 31st January 2018

Partnering for improved cancer care around the globe

“A medicine is only as good as the system that delivers it,” said Dr. Harald Nusser, Head of Novartis Social Business, when Novartis joined forces with the American Society for Clinical Pathology and the American Cancer Society in 2017 to fight cancer, including breast cancer, in Africa. Approximately 650 000 people develop cancer annually in Africa, and about 510 000 cancer deaths happen eac...

Monday 29th January 2018

Compound designed to fight Alzheimer’s disease shows promise in the lab

The year was 1906, and German physician Alois Alzheimer was examining the brain of a patient who had died after a battle with progressive dementia. The woman had experienced memory loss and other psychological changes. Alzheimer noticed the accumulation of a peculiar substance in the cortex, the first observation of what would later be called amyloid plaques.Fast forward more than 100 years and ma...

Tracking patients’ progress with radio signals and machine learning

In 2016, Jason Laramie attended a talk at the Massachusetts Institute of Technology (MIT) about a device that can see through walls. It can detect people, track their movement and breathing, and even see their hearts beating.Laramie, an Executive Director in Translational Medicine at the Novartis Institutes for BioMedical Research (NIBR), was taken aback. He wasn’t alone. “An audible buzz ripp...

Wednesday 20th December 2017

Organic dealmaker for drug discovery

In school, chemistry entranced Prakash Raman. But it was the tailoring of molecules – analyzing their structures and making strategic additions in select places – that he enjoyed most. The work was not only fascinating, but purposeful. Chemistry gave him the power to make medicine.“I couldn’t believe that as a chemist, I could make a difference by finding new drugs for patients,” he says...

Open science demystified

Before joining Novartis, Jay Bradner was a cancer researcher and pioneer of the growing trend toward open scientific innovation. He believes that in science, more minds are better. The more people working on tough scientific puzzles, the more likely they will be to find solutions. Now, as President of the Novartis Institutes for BioMedical Research (NIBR), he is applying this mindset to accelerat...

Wednesday 6th December 2017

Pioneering business approach expands healthcare in Indian villages

On a muggy Thursday in July, Chankey Kumar awoke early, as usual, in the two-bedroom home he, his wife and their infant son share with his parents, aunt, uncle, and two young cousins. He slipped on a blue collared shirt and dress pants — a formality that is unusual where he lives in a working-class neighborhood on the outskirts of Meerut, India, a city several hours north of New Delhi. ...

Monday 4th December 2017

Researchers overcome hurdles to test experimental malaria drug

Dr. Bakary Fofana and two colleagues sit at a desk in a health clinic and research lab in southern Mali, writing an email to their collaborators in the United States. Two pre-labeled test tubes for patient blood samples broke during the three-week transit from the US to Mali.Dr. Fofana has plenty of extra test tubes lying around, but the broken tubes are unique to the clinical trial of an experime...

Wednesday 15th November 2017

Women in Science: Shilpa Shah-Mehta

At ...

Thursday 9th November 2017

Conversations with Patient Advocates: Ron Hollander, president of INCA

We believe we can make a greater difference through collaboration. That is why we are excited to introduce a new series – called “Novartis Connects: Conversations with Patient Advocates” – that will showcase stories from many of the patient advocacy groups working with Novartis. These organizations are helping us connect with the cancer community on a more personal level so we can better u...

Quick Search


News Quicklinks